Novadiscovery services

Explore various regimens (dose, number of administrations per day, time between administrations, duration of treatment). Identify subgroups of optimal responders / theranostic biomarkers. Leverage real-world data to inform clinical trial design.

Demonstrate value to payers. Transpose Phase 3 trial results into an estimation of the drug’s public health impact. Benchmark against competing treatments.

Select the right target. Explore combinations of target/treatments. Support the translation from animal to man.